69 related articles for article (PubMed ID: 17514685)
21. Effects of angiotensin-converting enzyme inhibitor versus valsartan on cellular signaling events in heart transplant.
White M; Ross H; Levesque S; Whittom L; Pelletier GB; Racine N; Meloche S; Voisin L
Ann Pharmacother; 2009 May; 43(5):831-9. PubMed ID: 19417110
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction.
Palaniyappan A; Uwiera RR; Idikio H; Menon V; Jugdutt C; Jugdutt BI
Mol Cell Biochem; 2013 Apr; 376(1-2):175-88. PubMed ID: 23361363
[TBL] [Abstract][Full Text] [Related]
23. Valsartan - first angiotensin II receptor blocker licensed for post-MI use.
Cardiovasc J S Afr; 2005; 16(1):62. PubMed ID: 15778781
[No Abstract] [Full Text] [Related]
24. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
[TBL] [Abstract][Full Text] [Related]
25. Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy.
Wang SB; Foster DB; Rucker J; O'Rourke B; Kass DA; Van Eyk JE
Circ Res; 2011 Sep; 109(7):750-7. PubMed ID: 21817160
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5beta.
Xu C; Zhang X; Yu C; Lu G; Chen S; Xu L; Ding W; Shi Q; Li Y
Proteomics; 2009 Jan; 9(2):409-19. PubMed ID: 19142948
[TBL] [Abstract][Full Text] [Related]
27. Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system.
Maslov LN; Lishmanov YB; Oeltgen PR; Barzakh EI; Krylatov AV; Govindaswami M; Brown SA
Life Sci; 2009 May; 84(19-20):657-63. PubMed ID: 19245818
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II receptor blockade improves matrix metalloproteinases/tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardium.
Yang D; Ma S; Li D; Tang B; Yang Y
Biochem Biophys Res Commun; 2009 Oct; 388(3):606-11. PubMed ID: 19695229
[TBL] [Abstract][Full Text] [Related]
29. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
30. Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice.
Gilson WD; Epstein FH; Yang Z; Xu Y; Prasad KM; Toufektsian MC; Laubach VE; French BA
J Am Coll Cardiol; 2007 Oct; 50(18):1799-807. PubMed ID: 17964046
[TBL] [Abstract][Full Text] [Related]
31. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
32. Detection of regional changes in protein levels in the in vivo canine model of acute heart failure following ischemia-reperfusion injury: functional proteomics studies.
Sawicki G; Jugdutt BI
Proteomics; 2004 Jul; 4(7):2195-202. PubMed ID: 15221779
[TBL] [Abstract][Full Text] [Related]
33. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
34. Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R.
Sivarajah A; Collino M; Yasin M; Benetti E; Gallicchio M; Mazzon E; Cuzzocrea S; Fantozzi R; Thiemermann C
Shock; 2009 Mar; 31(3):267-74. PubMed ID: 18636044
[TBL] [Abstract][Full Text] [Related]
35. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.
Wang S; Fei K; Xu YW; Wang LX; Chen YQ
Chin Med J (Engl); 2009 Jan; 122(1):61-7. PubMed ID: 19187619
[TBL] [Abstract][Full Text] [Related]
36. Anesthetic preconditioning confers acute cardioprotection via up-regulation of manganese superoxide dismutase and preservation of mitochondrial respiratory enzyme activity.
Chen CH; Liu K; Chan JY
Shock; 2008 Feb; 29(2):300-8. PubMed ID: 17693941
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
39. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
Imanishi T; Ikejima H; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertens Res; 2008 Jun; 31(6):1199-208. PubMed ID: 18716369
[TBL] [Abstract][Full Text] [Related]
40. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
